Treatment with TH2 cytokines (IL-4, IL-5 and IL-13) significantly decreased hBD1 mRNA expression in the collagen-based AD model, whereas the expression of other AMPs analyzed, including hBD2 and LL-37, was not significantly affected (Fig. 6B). This evidence concerns the gene CAMP and Alzheimer disease.